×
Read More About ORGOVYX® (relugolix) and Register For Updates. Find Information Here. Learn About the Efficacy and Safety of ORGOVYX® (relugolix). View the Clinical Study. Full Prescribing Info. Clinical Trial Info.

Relugolix

Medication
Relugolix, sold under the brand names Orgovyx and Relumina among others, is a gonadotropin-releasing hormone antagonist medication which is used in the treatment of prostate cancer in men and uterine fibroids in women. It is taken by mouth. Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L02BX04 (WHO); H01CC54 (WHO) (combination with estradiol and norethisterone)
Elimination half-life: 36 to 65 hours
Other names: RGX; RVT-601; TAK-385
Pronunciation: /ˌrɛlʊˈɡoʊlɪks/; RE-luu-GOH-liks
Protein binding: 68–71%
PubChem CID: 10348973